XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.21.1

License and Collaboration Agreements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
License And Collaboration Agreements [Abstract] |
License, Collaboration and Other Revenue | In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):
|  |  |  | Three months ended March 31,
Partner |  | Drug Candidate |  | 2021 |  | 2020
Bristol-Myers Squibb Company |  | Bempegaldesleukin |  | $ | — |  |  | $ | 25,000 |
Eli Lilly and Company |  | NKTR-358 |  | — |  |  | 1,259 |
Other |  |  |  | 54 |  |  | 1,256 |
License, collaboration and other revenue |  |  |  | $ | 54 |  |  | $ | 27,515 |

X
- Definition License and collaboration agreements. + References No definition available. + Details
Name: | nktr_LicenseAndCollaborationAgreementsAbstract
Namespace Prefix: | nktr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration